<DOC>
	<DOCNO>NCT00690079</DOCNO>
	<brief_summary>The study perform order learn safety tolerability AZD1386 . AZD1386 primary intend treatment chronic pain .</brief_summary>
	<brief_title>Study Investigate Safety , Tolerability Pharmacokinetics AZD1386</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Healthy Caucasians , male female age ≥20 ≤ 45 year 65 80 year . Female subject must surgically sterile postmenopausal least 12 month prior enrolment visit . Body Mass Index ( BMI ) ≥18 ≤ 30 kg/m2 weight ≥50 ≤100 kg Clinically normal physical finding include heart rate &gt; 45 bpm laboratory value normal rest ECG History somatic psychiatric disease/condition , may interfere objective study . History severe allergy/hypersensitivity symptoms/signs ongoing allergy/hypersensitivity . Subjects high decrease blood pressure within 5 minute go supine stand position .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>MAD</keyword>
	<keyword>Multiple ascend dose</keyword>
	<keyword>Chronic pain</keyword>
	<keyword>pain</keyword>
</DOC>